An audience of MPN patients and their caregivers joined us at a recent town meeting at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University to hear the latest treatment and research news, inspiring stories of people living well with MPNs, tips for effective communication with a healthcare team and more.
We are also planning events in other cities. If you haven’t already, please sign up for email updates so we can alert you when important and inspiring videos become available and when upcoming events are scheduled.
How often should MPN patients have a bone marrow biopsy? Dr. Brady Stein and Dr. Stephen Oh discuss their views on when and why patients should have a bone marrow biopsy.
Is there a remedy for itching in MPN patients? Dr. Stephen Oh addresses the often bothersome issue of itching in patients with myeloproliferative neoplasms (MPNs), particularly with polycythemia vera (PV).
Dr. Brady Stein and physician assistant Lindsey Kalhagen from Northwestern Medicine address the ambiguity of cognitive issues in MPN patients and whether symptoms are related to stress or other factors.
Dr. Stephen Oh from Washington University School of Medicine and Dr. Brady Stein from Northwestern Medicine discuss the role of stem cell transplant for the treatment of MPNs as well as the risks of the procedure.
Dr. Stephen Oh from Washington University School of Medicine and Dr. Brady Stein from Northwestern Medicine examine genetic testing as it relates to the prognosis and treatment of myeloproliferative neoplasms (MPNs).
Dr. Brady Stein from Northwestern Medicine and Dr. Stephen Oh from Washington University School of Medicine discuss the impact of telomerase inhibitors and the potential to reverse fibrosis.
Dr. Brady Stein from Northwestern Medicine discusses combination therapies for MPNs that are currently being evaluated in clinical trials. He explains the function of JAK inhibitors and their effectiveness when being combined with other therapies.
Assistant Professor, Department of Medicine, Hematology Oncology Division, Feinberg School of Medicine
Assistant Professor, Division of Hematology
Washington University School of Medicine
Chancellor Professor Emerita and Patient Power Host
University of Massachusetts, Dartmouth
This event was brought to you by Patient Power and the Lurie Cancer Center and is sponsored by the Incyte Corporation, Baxter International Inc. and CTI BioPharma